Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

Title
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system
Authors
Keywords
Antiviral, Coronavirus, COVID-19, Library, SARS-CoV-2, Treatment, Cetilistat, Diiodohydroxyquinoline, Abiraterone, Bexarotene
Journal
PHARMACOLOGICAL RESEARCH
Volume -, Issue -, Pages 104960
Publisher
Elsevier BV
Online
2020-05-28
DOI
10.1016/j.phrs.2020.104960

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started